A website to provide support for people who have or have had any type of cancer, for their caregivers and for their family members.
Page 3 of 3 FirstFirst 123
Results 21 to 23 of 23

Thread: Hoping for options after relapse of AITL.

  1. #21
    Super Moderator Top User po18guy's Avatar
    Join Date
    Feb 2012
    Posts
    9,914
    I just completed participation in my 4th clinical trial. Two for lymphoma and two for graft-versus-host-disease. I guess my only question would be, why not a trial of a new drug combo? Most lymphomas respond to drug combinations rather than single agent drugs. Nevertheless, you can save some money and hassle by at least beginning the trial. The sponsoring company will pay for the drug as well as all study-related costs (scans and supplies, etc.) and often will compensate for mileage and lunches. If response is less than expected, then you simply withdraw from the trial and initiate plan B, C or D.

    Which, by the way, are plans that any T-Cell hematologist should have in hand. They need to stay three steps ahead of the lymphoma. There are plenty of drug for relapsed T-Cell Lymphoma. Romidepsin, Pralatrexate, Belinostat, Mogamulizumab, TEC (Bendamustine, Etoposide, Carboplatin) and some others that I am probably forgetting.

  2. #22
    Regular User
    Join Date
    Mar 2018
    Posts
    11
    So far on the trial drug Cerdulatinib for a week and itís very tolerable. Had my one week visit yesterday and bloodwork was all good. Pancreatic enzymes are high which is expected but if no symptoms treatment can continue. Surprisingly the spots on my tailbone are already responding. The color has faded and the lumpy texture has gone away. The one node I can feel in my groin is responding as well. Hoping for continued favorable progress.

  3. #23
    Super Moderator Top User po18guy's Avatar
    Join Date
    Feb 2012
    Posts
    9,914
    That is great news! Since I have been out of the lymphoma treatment arena for three years, this was a new one to me. After looking it up, I see that its potential is huge and the FDA has already granted orphan drug status to it, opening the door to further research and development. It also seems to show promise against certain autoimmune conditions, which is also very good news. Here is a company press release from this past September:

    https://globenewswire.com/news-relea...-Lymphoma.html

 

Similar Threads

  1. Kay - AITL relapse?
    By [email protected] in forum Lymphoma - Hodgkin's and Non-Hodgkin's Lymphoma Forum
    Replies: 3
    Last Post: 05-26-2016, 02:20 PM
  2. Grandfather diagnosed with AITL -- options for prolonging life, even if short-term
    By lovemygrandpa in forum Lymphoma - Hodgkin's and Non-Hodgkin's Lymphoma Forum
    Replies: 14
    Last Post: 01-31-2015, 05:58 AM
  3. 4 RCHOPS or 6 in fNHL after remission, & chances of relapse, treatments if so?
    By Eyam in forum Lymphoma - Hodgkin's and Non-Hodgkin's Lymphoma Forum
    Replies: 6
    Last Post: 05-27-2012, 08:20 AM
  4. MCL relapse after autoSCT
    By Rmillnj in forum Lymphoma - Hodgkin's and Non-Hodgkin's Lymphoma Forum
    Replies: 3
    Last Post: 03-25-2012, 02:55 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •